US 8202990
Polo-like kinase inhibitors
granted A61PA61P1/04A61P11/00
Quick answer
US patent 8202990 (Polo-like kinase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61P, A61P1/04, A61P11/00, A61P13/00, A61P13/12